| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Revenue | $1.68B | +31.1% |
| Cost of Revenue | $424.5M | +21.5% |
| Gross Profit | $1.26B | +34.6% |
| R&D Expense | $515.9M | +22.3% |
| SG&A Expense | $193.6M | +20.6% |
| Operating Income | -$233.7M | +32.6% |
| Interest Expense | $9.4M | -4.2% |
| Pre-tax Income | -$163.5M | +50.9% |
| Income Tax | $13.1M |
| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $803.0M | +76.2% |
| Accounts Receivable | $325.6M | +14.2% |
| Current Assets | $2.48B | +11.0% |
| Total Assets | $2.87B | +10.8% |
| Current Liabilities | $564.2M | -4.1% |
| Total Liabilities | $1.80B | -2.6% |
| Stockholders' Equity | $1.07B | +44.6% |
| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $121.5M | +1036.6% |
| Capital Expenditures | $6.1M | -16.2% |
| Investing Cash Flow | $188.0M | +664.5% |
| Financing Cash Flow | $38.2M | +26.6% |
| Free Cash Flow | $115.4M | +670.9% |
| +7.7% |
| Net Income | -$176.6M | +48.9% |
| EPS (Basic) | -$2.48 | +50.7% |
| EPS (Diluted) | -$2.48 | +50.7% |